Adult Stem Cell Therapy for Stroke: Challenges and Progress

Stroke is one of the leading causes of death and physical disability among adults. It has been 15 years since clinical trials of stem cell therapy in patients with stroke have been conducted using adult stem cells like mesenchymal stem cells and bone marrow mononuclear cells. Results of randomized c...

Full description

Bibliographic Details
Main Authors: Oh Young Bang, Eun Hee Kim, Jae Min Cha, Gyeong Joon Moon
Format: Article
Language:English
Published: Korean Stroke Society 2016-09-01
Series:Journal of Stroke
Subjects:
Online Access:http://www.j-stroke.org/upload/pdf/jos-2016-01263.pdf
_version_ 1818446373620547584
author Oh Young Bang
Eun Hee Kim
Jae Min Cha
Gyeong Joon Moon
author_facet Oh Young Bang
Eun Hee Kim
Jae Min Cha
Gyeong Joon Moon
author_sort Oh Young Bang
collection DOAJ
description Stroke is one of the leading causes of death and physical disability among adults. It has been 15 years since clinical trials of stem cell therapy in patients with stroke have been conducted using adult stem cells like mesenchymal stem cells and bone marrow mononuclear cells. Results of randomized controlled trials showed that adult stem cell therapy was safe but its efficacy was modest, underscoring the need for new stem cell therapy strategies. The primary limitations of current stem cell therapies include (a) the limited source of engraftable stem cells, (b) the presence of optimal time window for stem cell therapies, (c) inherited limitation of stem cells in terms of growth, trophic support, and differentiation potential, and (d) possible transplanted cell-mediated adverse effects, such as tumor formation. Here, we discuss recent advances that overcome these hurdles in adult stem cell therapy for stroke.
first_indexed 2024-12-14T19:46:42Z
format Article
id doaj.art-b0fa8fc355d142c0832400f360575b29
institution Directory Open Access Journal
issn 2287-6391
2287-6405
language English
last_indexed 2024-12-14T19:46:42Z
publishDate 2016-09-01
publisher Korean Stroke Society
record_format Article
series Journal of Stroke
spelling doaj.art-b0fa8fc355d142c0832400f360575b292022-12-21T22:49:33ZengKorean Stroke SocietyJournal of Stroke2287-63912287-64052016-09-0118325626610.5853/jos.2016.01263149Adult Stem Cell Therapy for Stroke: Challenges and ProgressOh Young Bang0Eun Hee Kim1Jae Min Cha2Gyeong Joon Moon3 Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Translational and Stem Cell Research Laboratory on Stroke, Samsung Medical Center, Seoul, Korea Samsung Biomedical Research Institute, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Seoul, Korea Translational and Stem Cell Research Laboratory on Stroke, Samsung Medical Center, Seoul, KoreaStroke is one of the leading causes of death and physical disability among adults. It has been 15 years since clinical trials of stem cell therapy in patients with stroke have been conducted using adult stem cells like mesenchymal stem cells and bone marrow mononuclear cells. Results of randomized controlled trials showed that adult stem cell therapy was safe but its efficacy was modest, underscoring the need for new stem cell therapy strategies. The primary limitations of current stem cell therapies include (a) the limited source of engraftable stem cells, (b) the presence of optimal time window for stem cell therapies, (c) inherited limitation of stem cells in terms of growth, trophic support, and differentiation potential, and (d) possible transplanted cell-mediated adverse effects, such as tumor formation. Here, we discuss recent advances that overcome these hurdles in adult stem cell therapy for stroke.http://www.j-stroke.org/upload/pdf/jos-2016-01263.pdfstrokebiomaterialsstem cellsmesenchymal stem cells
spellingShingle Oh Young Bang
Eun Hee Kim
Jae Min Cha
Gyeong Joon Moon
Adult Stem Cell Therapy for Stroke: Challenges and Progress
Journal of Stroke
stroke
biomaterials
stem cells
mesenchymal stem cells
title Adult Stem Cell Therapy for Stroke: Challenges and Progress
title_full Adult Stem Cell Therapy for Stroke: Challenges and Progress
title_fullStr Adult Stem Cell Therapy for Stroke: Challenges and Progress
title_full_unstemmed Adult Stem Cell Therapy for Stroke: Challenges and Progress
title_short Adult Stem Cell Therapy for Stroke: Challenges and Progress
title_sort adult stem cell therapy for stroke challenges and progress
topic stroke
biomaterials
stem cells
mesenchymal stem cells
url http://www.j-stroke.org/upload/pdf/jos-2016-01263.pdf
work_keys_str_mv AT ohyoungbang adultstemcelltherapyforstrokechallengesandprogress
AT eunheekim adultstemcelltherapyforstrokechallengesandprogress
AT jaemincha adultstemcelltherapyforstrokechallengesandprogress
AT gyeongjoonmoon adultstemcelltherapyforstrokechallengesandprogress